ACR Convergence 2024

November 14-19, 2024. Washington, DC.

View by Number View by Title View Sessions

Abstract Number: 1300

Tackling Rheumatology Workforce Shortages with a Case-Based Primary Care Rheumatology Curriculum
Abstract Number: 1301

Assessment and Comparison of Long-term Skill Retention Following a Teledidactic Musculoskeletal Ultrasound Course for Medical Students– the TELMUS Follow-up Study
Abstract Number: 1302

Physician Knowledge, Attitudes and Perceived Barriers to Recommending the Recombinant Varicella Zoster Vaccine
Abstract Number: 1303

Knee Injection Training for Internal Medicine Residents in Real-world Primary Care Practice
Abstract Number: 1304

Assessing Knowledge and Aptitude in Antinuclear Antibody Testing Among Internal Medicine Residents
Abstract Number: 1305

Bingo: A Winning Pediatric Rheumatology Teaching Strategy?
Abstract Number: 1306

A Comparative Analysis of ChatGPT-4, Microsoft’s Bing and Google’s Bard at Answering Rheumatology Clinical Questions
Abstract Number: 1307

Multidisciplinary Participation in Online Rheumatology Discussion Forums
Abstract Number: 1308

Measuring the Educational Impact of a Collaboration Between RheumMadness and TheMednet
Abstract Number: 1309

Bridging the Gap: Evaluating Ophthalmology Training Amongst Pediatric Rheumatology Fellows
Abstract Number: 1310

Cadaver Lab Improves Rheumatology Trainees’ Skills in Identifying Joint Anatomy and Performance of Joint Procedures
Abstract Number: 1311

“A Fellow-Driven Voluntary Initiative in Musculoskeletal Ultrasound Training: Interest Does Not Equal Attendance”
Abstract Number: 1312

Long Term Proficiency and Clinical Outcomes of a Novel Fellow’s Injection Clinic
Abstract Number: 1313

The Impact of Rheumatology Fellow Initiated Curriculum Design on Resident Education for R1 versus R2-R4 Learners
Abstract Number: 1314

Creation of an Online, Self-Assessment Tool for “Clinical Competencies in Telerheumatology”

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].